clinical trial · NCT04782180
PrEP at a Syringe Services Program
University of Miami·phase4·completed·n = 90
HivSubstance Use DisordersDescovy 200Mg 25Mg TabletPrEP
brief summary
The purpose of this study is to see if providing participants with pre-exposure prophylaxis (PrEP) medicine right away at the IDEA Exchange will help participants remain in HIV negative.
started
Feb 1, 2022
primary completion
Nov 11, 2024
completion
Nov 11, 2024
last updated
Dec 19, 2025
official title
Mobile Delivery of PrEP at a Syringe Services Program-A Pilot Study
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol